Sichuan Furong Technology Co Ltd

Furong Technology's non-public share issuance application was accepted by the Shanghai Stock Exchange on August 25. The proposed issuance size is no more than 40.6504 million shares, with expected proceeds of 300 million yuan. The sponsor is Industrial Securities.

In early trading on July 16, Harbin Pharmaceutical hit its fifth consecutive daily limit, making it the stock with the longest winning streak among those still on a streak that day. The innovative drug theme remained strong, with Wanbang Pharmaceutical and Puruis rising over 10 percent. The on-device AI concept heated up, as Green Precision sealed a 20 percent daily limit, and Daoming Optics and Furong Technology also hit their daily limits. On the news front, seven on-device generative AI services completed regulatory filings, and the 2026 World Artificial Intelligence Conference is set to take place in Shanghai. The brain engineering sector saw a sudden surge during the session, with Chuangxin Medical hitting its daily limit in a straight line, and Saili Medical and Aipeng Medical following higher. The world's first implantable brain-computer interface system, NEO, saw its first prescription issued in Shanghai after receiving market approval. Total market turnover exceeded 1.4 trillion yuan, shrinking by 236.7 billion yuan compared with the same period last session, with over 3,200 stocks advancing.

On July 3, the foldable display concept sector was active during the session. Furong Technology surged in a straight line to hit its daily limit up, with stocks such as Yian Technology, Anjie Technology, Jingyan Technology, and Liande Equipment following closely behind in a rising trend.